JP Patent

JP5134548B2 — 過剰増殖性疾患の処置のためのＥｒｂＢＩ型受容体チロシンキナーゼ阻害剤としてのＮ４−フェニルキナゾリン−４−アミン誘導体および関連化合物

Assigned to アレイ バイオファーマ、インコーポレイテッド · Expires 2013-01-30 · 13y expired

What this patent protects

Patent listed against Hernexeos.

Drugs covered by this patent

Patent Metadata

Patent number
JP5134548B2
Jurisdiction
JP
Classification
—
Expires
2013-01-30
Drug substance claim
No
Drug product claim
No
Assignee
アレイ バイオファーマ、インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.